Trial Condition(s):
Placebo and active controlled, double dummy study to compare efficacy of Aspirin and Ibuprofen in treatment of episodic tension-type headache
11220
Not Available
Not Available
The purpose of this study is to determine the efficacy and tolerability of 500 mg and 1000 mg Aspirin® (study medication) by comparing it to placebo (the control group without active substance) or 200 mg or 400 mg Ibuprofen (study medication) in treating the symptoms of episodic tension-type headache. The study is designed to develop a treatment method against episodic tension-type headache which will have more advantages for patients than the methods that are currently available.
- Ambulatory male or female, 18 to 65 years of age - Normal blood pressure - Patients suffering from episodic tension-type headache - Headache lasting from 30 minutes to 7 days - Headache had at least two of the following characteristics: Bilateral location. Pressing/tightening (non-pulsating). Mild or moderate intensity. Not aggravated by routine physical activity such as walking or climbing stairs. - Both of the following: No nausea or vomiting. No more than one of photophobia or phonophobia.
- Other headaches, including migraine, that required medical treatment - Hypersensitivity to acetylsalicylic acid, salicylates, ibuprofen or other non-steroidal anti-inflammatory drugs (NSAIDs) - Serious physical illness especially uncontrolled disorders of kidney, liver, lung, heart or brain function, neurological disorders or severe chronic or terminal disease - Mental illness, including depression - Needed or were using or likely to need or use any of the prohibited concomitant medications: antidepressants, oxicams - Pregnant or lactating women, or sexually active women of child-bearing potential unless using effective contraception - Participating in any other clinical study or had done within the previous 4 weeks - Had been previously enrolled in this study
Locations | |
---|---|
Locations Investigative Site Birmingham, United Kingdom, B15 2SQ | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Coventry, United Kingdom, CV1 2TZ | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Chorley, United Kingdom, PR7 1NY | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Liverpool, United Kingdom, L22 0LG | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Liverpool, United Kingdom, L1 9AD | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Reading, United Kingdom, RG2 7AG | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Wolverhampton, United Kingdom, WV10 9RU | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Wigan, United Kingdom, WN6 9EW | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Cardiff, United Kingdom, CF14 5GJ | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Glasgow, United Kingdom, G20 OSP | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Manchester, United Kingdom, M15 6SX | Contact Us: E-mail: [email protected] Phone: Not Available |
A multicentre randomised parallel-groups double-blind double-dummy single-dose study to compare Acetylsalicylic acid 500 mg and 1,000 mg with Ibuprofen 200 mg and 400 mg and Placebo for tolerability and efficacy in the treatment of episodic tension-type headache
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Randomized
Blinding:
Double Blind
Assignment:
Parallel Assignment
Trial Arms:
5